National Institute of Mental Health and Neurosciences

Slides:



Advertisements
Similar presentations
K OREAN ADNI … WHERE ARE WE NOW Seol-Heui Han, MD, PhD. On behalf of Preparatory Committee for K-ADNI Seol-Heui Han, MD, PhD. On behalf of Preparatory.
Advertisements

The Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing AUSTRALIAN ADNI. July 2010 UPDATE.
Department of Neurology, Mayo Clinic Arizona
Alzheimer’s Disease Neuroimaging Initiative STEERING COMMITTEE April
ADNI 3 Clinical Core Plans
Poster Title Author(s) Institution Poster Title Author(s) Institution INTRODUCTION HISTORY SIMSCON th South Indian Medical Students’ Conference,
Brain Research Methods!
EPAD update José Luis Molinuevo Worldwide-ADNI Update Meeting Friday, July 17, 2015 Washington, D.C.
Epidemiology of Dementia: the MoVIES Project Alzheimer’s Disease Patient Registry (ADPR ), University of Pittsburgh Initially funded by NIA under.
©2012 MFMER | ADNI Clinical Core Paul Aisen Ron Petersen Michael Donohue Jennifer Salazar.
COST CM1103 Training School Structure-based drug design for diagnosis and treatment of neurological diseases Istanbul, 9-13 Sept 2013 Mirjana Babić, mag.biol.mol.
HOW CAN NEUROIMAGING HELP UNDERSTAND, DIAGNOSE, AND DEVELOP TREATMENTS FOR ALZHEIMER'S DISEASE? Part C – AD brain scans - anatomical NUCLEAR MEDICINE GRAND.
Consent for Research Study A study using 18 F-Fluoride for prostate cancer patients currently enrolled in Dr. Febbo’s “Genomic Guided Therapy” study A.
Alzheimer’s Disease Neuroimaging Initiative STEERING COMMITTEE Michael W. Weiner.
©2012 MFMER | ADNI Clinical Core Paul Aisen Ron Petersen Michael Donohue Jennifer Salazar ADNI Steering Committee Meeting Washington, DC April.
Update Arg-ADNI Instituto de Investigaciones Neurológicas (FLENI)
Methods to Study the Brain. The Brain How do we learn about the brain & its functions?
Apolipoprotein E and Gray Matter Loss in Mild Cognitive Impairment and Alzheimer’s Disease Spampinato MV, Goldsberry G, Mintzer J, Rumboldt Z Medical University.
Structural and Functional Neuroimaging in the Diagnosis of Dementia John M. Ringman, M.D. Assistant Professor UCLA Department of Neurology.
Laboratory of Neuro Imaging: Graduate Students Sarah K. Madsen Mentor: Paul M. Thompson, Ph.D. Committee: Susan Y. Bookheimer, Ph.D., Jamie D. Feusner,
Date of download: 6/3/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Mechanism of Amyloid Removal in Patients With Alzheimer.
DECIDE: "Scientific and Clinical Perspectives“: Claudio Babiloni (UNIFG) and Giovanni Frisoni (IRCCS Brescia)
HIS 112 Week 5 DQ 1 The early Middle Ages can be characterized by a decline of the centralized urban institutions of late antiquity and the emergence of.
Laura Baker, PhD Internal Medicine, Neurology, & Public Health Sciences Wake Forest School of Medicine Winston-Salem, NC USA.
ADNI3 Clinical core Paul Aisen Ron Petersen Mike Donohue
Aka STEEL VALLEY SENIORS SURVEY (SVSS)
José L Molinuevo, Craig Ritchie, Miia Kivipelto
INDIA - ADNI Dr Naren Rao
INDIA - ADNI Dr Naren Rao
Bilingualism or multilingualism has protective effect on dementia onset: is there any evidence? A systematic review Yadav AK, Yadav J, Kumar P, Sagar R,
Alzheimer’s Disease Neuroimaging Initiative 3 (ADNI 3)
Alzheimer’s Disease Neuroimaging Initiative 3 (ADNI 3)
Presenter: Dr. Patricio Chrem
Paul Aisen Ron Petersen Michael Donohue Jennifer Salazar
Gemma Stringer Manchester Dementia Clinical Research Group
COMBINATION OF CSF PROTEIN BIOMARKERS AND BDNF, IL10 AND IL6 GENOTYPES IN EARLY DIAGNOSIS OF ALZHEIMER’S DISEASE   Mirjana Babić Leko1, Matea Nikolac Perković2,
Whole Genome Methylation and MTHFR (C677T) polymorphism in Alcohol Dependence Bhagyalakshmi Shankarappa; Anirrudh Basu; Shwetha Byrappa; Rashmi Chandra;
Epidemiology of Dementia: the MoVIES Project
Neural.
Excessive day time sleepiness as assessed by Modified Epworth Sleepiness Scale among urban elderly population: Results from the preliminary data of AIIMS.
SABRE (Southall and Brent Revisited) Association of mid-life vascular risk factors associated with late-life hippocampal volume: A prospective multi-ethnic.
Table 2. Data Sharing for (Reporting Period)
Volume 2, Issue 1, Pages (January 2016)
Dementia Risk Prediction Development of the first tool for LMICs (WS2)
Imaging AD Progression Amyloid Imaging Agents.
JAMA Ophthalmology Journal Club Slides: Validity of the Age-Related Eye Disease Study Grading Scale Vitale S, Clemons TE, Agrón E, et al; Age-Related Eye.
PPMI Beyond 2018.
INDIA - ADNI Dr Naren Rao
PPMI – GOALS 2019 Ken Marek PPMI Annual Meeting May 3, 2018
ADNI3 Clinical core Paul Aisen Ron Petersen Mike Donohue
José L Molinuevo, Craig Ritchie, Miia Kivipelto
ADNI Clinical Core Paul Aisen Ron Petersen Michael Donohue
Ron Petersen & Paul Aisen
Presenter: Dr. Patricio Chrem
Adam P. Spira, Ph.D. Associate Professor, Department of Mental Health
Does Multilingualism Protect Against Alzheimer’s Disease
Chris Hyde Exeter Test Group.
Alzheimer’s Disease Neuroimaging Initiative 3 (ADNI 3)
Argentina Arg-ADNI Ezequiel Surace, PhD.
The Cardiovascular Health Study:
Tharick A. Pascoal, Sulantha Mathotaarachchi, Monica Shin, Andrea L
Gait Sub study Anat Mirelman PhD.
Rubin Becker MD FRCP© Associate Professor McGill University Medical Consultant Manulife and OptimumRe.
UC Davis Data Summary Psychometrics 2018.
ADNI 3 UPDATE MICHAEL WEINER.
Interreg-IPA Cross-border Cooperation Programme Romania-Serbia
Detecting and Diagnosing Alzheimer’s Disease
Alzheimer's Prevention Research and
Ongoing Research With Vascular Risk Factors and the RAS in Individuals at Risk for AD Whitney Wharton, PhD Assistant Professor,
in Younger and Older African Americans and Whites
Presentation transcript:

National Institute of Mental Health and Neurosciences INDIA - ADNI Dr Naren Rao Indian Institute of Science National Institute of Mental Health and Neurosciences

Tata Longitudinal study of Aging Funded by Tata trust, a private philanthropy A longitudinal study assessing cognitive change in Urban population Age for inclusion >50 years Baseline visit and annual follow up (follow up changed to Once in 2 years)

Schedule of events Assessments MRI Telephonic screening Genotyping Clinical assessment Cognitive assessment Blood investigation MRI PET (18F-FDG) Carotid Doppler Genotyping

Cognitive and Clinical examination Current status Baseline Cognitive and Clinical examination MRI PET 226 124 44 Follow up (year 1) 48 32 Follow up visit (Year 2) 11 5 2

Place of origin

Medical comorbidities

Medical comorbidities

ADNI 2 PROTOCOL MRI – Siemens Skyra PET/CT – GE discovery Siemens PRISMA purchase is in progress – will be shifted to ADNI 3 protocol

WHITE MATTER HYPERINTENSITY

Srinivaspura Aging, Neuro Senescence and COGnition (SANSCOG) Study Bengaluru GC: Added IISc logo as many of them are part of the study and will be in the meeting. Sri Devaraj Urs Academy of Higher Education and Research

Rural cohort of >45 years (n=10,000; MRI -1,000) 30 min Screening & Informed Consent Sociodemographic & Brief clinical Assessment Home visit 2-3 weeks 3 hrs Detailed cognitive Assessment Detailed clinical assessment Biochemistry & Genetics Eye fundus photograph Carotid doppler 2-3 weeks Study site 2 hrs MRI (ADNI 3 protocol) PET Wrist actigraphy MRI/PET

Study components Recruitment of subjects Clinical assessments Cognitive assessments (COGNITO adapted to India) Magentic resonance imaging (MRI) Positron emission tomography (PET) – tau & amyloid Biochemical measures Carotid doppler Activity monitoring with wearable devices Genetics – whole genome sequencing/ GWAS and storage

Progress so far (n=370)

PET/MRI – Siemens Biograph – simultaneous PET-MRI ADNI 3 PROTOCOL MRI -– Philips Ingenia PET/MRI – Siemens Biograph – simultaneous PET-MRI Siemens PRISMA purchase is in progress – will be used in addition to Ingenia

UNIQUENESS Rural and Urban population cohorts Different environmental and socio-cultural factors Younger population (above 45 years) Higher proportion vascular risk factors and nutritional deficiency Considerable proportion of Illiterate population (Education level = 0); Cognitive tests and instruments have been modified and validated

AT AAIC, 2018 P2-449 Relation between Corpus Callosum Volume and Brain Glucose Metabolism in Middle Aged Individuals Ranjini Garani Ramesh, Simran Purokayastha, Mahendra Javali, Kumar Kallur, Naren Rao Poster #26610 Date: Monday, July 23, Location: McCormick Place, Hall - F1 update

AT AAIC, 2018 Poster #26606 Date: Tuesday, July 24 P3-385 Corpus Callosum Volume and Executive Function: A Potential Early Marker of Cognitive Decline Simran Purokayastha1, Ranjini Garani Ramesh1, Mahendra Javali2 , Kumar Kallur3 and Naren Prahalada Rao1,4 Poster #26606 Date: Tuesday, July 24 Location: McCormick Place, Hall - F1 Update FDG

P2-107 The epsilon4 Allele Frequency of Apoe and Its Association with Mild Cognitive Impairment/Alzheimer’s Disease Status in South Indians Ganesh Chauhan, Naren Prahalada Rao, Suvarna Alladi, Diji Kuriakose, Ranjini Garani Ramesh, Simran Purokayastha, Mahendra Javali and Vijayalakshmi Ravindranath Poster #26422 Date: Monday, July 23 Location: McCormick Place, Hall - F1 AT AAIC, 2018

THANK YOU